CRL - CIK 0001100682
The table below shows CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $41.08M | $171.70M | $129.89M | $109.38M | $102.63M | $170.23M |
| Capital expenditure | - | - | - | - | - | - |
| Investing cash flow | -$407.85M | -$45.48M | -$85.79M | -$168.62M | -$98.00M | -$138.00M |
| Dividends paid | - | - | - | - | - |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported operating cash flow of $737.65M for fiscal year 2025. That is up 0.4% from $734.58M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $316.90M (FY 2016) to $737.65M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | $208.28M | $353.13M | $9.35M | $19.01M | $33.99M | $36.03M |
| Financing cash flow | $347.72M | -$105.33M | $18.35M | $25.24M | -$13.28M | $194.72M |